About AVANTGEN INC
AvantGen is a biotechnology company focused on enabling scientific partners in the discovery and optimization of novel antibody drugs through innovative platforms and collaborative approaches. They utilize advanced yeast display technology and a large antibody repertoire for high-quality antibody development.
Antibody discovery and optimizationYeast display technology for antibody productionDevelopment of scFv, Fab, and VHH platformsLibrary design and engineering for lead candidate optimizationNK cell engager platform developmentHigh-throughput screening and validation of antibodies
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Health and Human Services | $3.8M | |
| DEVELOPMENT OF RABBIT MONOCLONAL ANTIBODIES FOR INDIAN FLYING FOX (BAT) BIOMARKERS | Department of Health and Human Services | $593K | |
| DEVELOPMENT OF RABBIT MONOCLONAL ANTIBODIES FOR FERRET BIOMARKERS. | Department of Health and Human Services | $1.5M | |
| TOPIC 372: DEVELOPMENT AND VALIDATION OF NON-MOUSE REAGENTS TO ENABLE PRECLINICAL DEVELOPMENT OF NOVEL THERAP | Department of Health and Human Services | $2.0M | |
| DEVELOPMENT OF RABBIT MONOCLONAL ANTIBODIES FOR FERRET BIOMARKERS | Department of Health and Human Services | $356K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AVANTGEN INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.